Segall Bryant & Hamill LLC Takes $2.02 Million Position in Maximus, Inc. $MMS

Segall Bryant & Hamill LLC purchased a new stake in Maximus, Inc. (NYSE:MMS) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 31,500 shares of the health services provider’s stock, valued at approximately $2,019,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of MMS. Dimensional Fund Advisors LP lifted its stake in Maximus by 7.2% during the first quarter. Dimensional Fund Advisors LP now owns 2,107,278 shares of the health services provider’s stock valued at $135,084,000 after buying an additional 141,362 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Maximus by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 1,482,079 shares of the health services provider’s stock valued at $127,952,000 after acquiring an additional 5,130 shares during the period. Van Berkom & Associates Inc. lifted its position in shares of Maximus by 3.7% in the 1st quarter. Van Berkom & Associates Inc. now owns 1,172,190 shares of the health services provider’s stock valued at $75,137,000 after acquiring an additional 41,862 shares in the last quarter. Boston Partners boosted its stake in Maximus by 47.0% in the 3rd quarter. Boston Partners now owns 966,139 shares of the health services provider’s stock worth $88,236,000 after purchasing an additional 308,892 shares during the period. Finally, River Road Asset Management LLC grew its position in Maximus by 236.1% during the 4th quarter. River Road Asset Management LLC now owns 823,262 shares of the health services provider’s stock worth $71,064,000 after purchasing an additional 578,326 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Stock Up 1.7%

Maximus stock opened at $63.27 on Wednesday. Maximus, Inc. has a twelve month low of $52.73 and a twelve month high of $100.00. The company has a debt-to-equity ratio of 0.87, a quick ratio of 2.21 and a current ratio of 2.21. The firm has a market cap of $3.32 billion, a PE ratio of 9.47 and a beta of 0.59. The firm’s 50 day moving average price is $58.75 and its two-hundred day moving average price is $68.05.

Maximus (NYSE:MMS) last issued its earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.98 by $0.09. Maximus had a net margin of 7.02% and a return on equity of 25.10%. The company had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.32 billion. During the same quarter last year, the business posted $2.01 EPS. The company’s revenue for the quarter was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. On average, research analysts predict that Maximus, Inc. will post 8.43 EPS for the current fiscal year.

Maximus Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Friday, August 14th. Maximus’s dividend payout ratio (DPR) is currently 19.76%.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Wall Street Zen upgraded Maximus from a “hold” rating to a “buy” rating in a report on Saturday, June 6th. Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Weiss Ratings lowered Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Two analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has an average rating of “Hold”.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.